SAADH, M. J. (2022). SARS-COV-2 3CL-PROTEASE INHIBITORS AS ANTIVIRAL AGENT AGAINST COVID-19. International Journal of Applied Pharmaceutics, 14(6), 18–20. https://doi.org/10.22159/ijap.2022v14i6.46015